Derek Maetzold

Derek J.
Maetzold is the founder of Castle Biosciences, Inc., founded in 2007, where the title held is President, Chief Executive Officer & Director.
Current jobs include Director at AltheaDx, Inc. since 2021, Director at Prelude Corp.
since 2022, Director at Ocular Melanoma Foundation, and Director at IMPACT Melanoma, Inc. Former jobs include Director & Associate Director-Marketing at Amylin Pharmaceuticals, Inc. from 1996 to 1998, Senior Director-Business Development at Schering-Plough Corp.
from 1999 to 2003, Associate Director-Marketing at Sandoz Pharmaceuticals Corp.
from 1985 to 1996, Vice President-Sales & Marketing at Encysive Pharmaceuticals, Inc. from 2003 to 2008, and Account Supervisor at Integrated Communications Corp.
from 1998 to 1999.
Education includes undergraduate studies at George Mason University.